Smith & Nephew

Smith & Nephew

Health Care Equipment & Supplies
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

$12.4B

Market Cap • 10/30/2026

1937

(89 years)

Founded

1999

(27 years ago)

IPO

NYSE

Listing Exchange

Flag of United Kingdom

United Kingdom

Country

Valuation

P/B

2,4

P/S

2

P/EBITDA

8,8

P/OCF

9,3

P/FCF

14,5

P/E

20,2

BVPS

12,4

EPS

1,5

Market Cap

Market Cap

12,4B

EV

15,5B

EV/Revenue

2,5

EV/EBITDA

10,9

EV/EBIT

19

Payout

Dividend Per Share

0,8

Dividend Yield

2,6%

Buyback Yield

4,9%

Total Yield

7,5%

Dividend Yield 5Y

2,6%

Payout

52,4%

Retained Earnings

5,4B

Profitability

Gross Margin

68,2%

EBITDA Margin

22,4%

EBIT Margin

12,9%

Net Margin

10,1%

D&A/EBITDA

0%

R&D/Revenue

4,8%

Capex/Revenue

7,7%

Capex/D&A

80,7%

Capex/OCF

36,1%

SBC/OCF

4,2%

% PPE

14,7%

% Goodwill

29,4%

ROE

11,9%

ROIC

7,4%

Growth

CAGR Revenue 5Y

4,2%

CAGR Op. Income 5Y

8,6%

CAGR Net Income 5Y

2,8%

CAGR EPS 5Y

3,1%

CAGR OCF 5Y

1,8%

Leverage

N.D./EBITDA

2,1

Debt/Equity

0%

Current Ratio

2,1

Quick Ratio

1,1

Interest Coverage

514,6%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium